Rennova Health, Inc. (RNVA) Financial Statements (2025 and earlier)

Company Profile

Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800
WEST PALM BEACH, FL 33401
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8062 - General Medical and Surgical Hospitals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49972525177 
Cash and cash equivalent49972525177 
Receivables5,4063,5931,9204,2084,4432,912
Inventory, net of allowances, customer advances and progress billings243281445614453237
Inventory243281445614453237
Disposal group, including discontinued operation   185505  
Asset, held-for-sale, not part of disposal group     140227
Other undisclosed current assets21512214907910
Total current assets:6,3634,7202,7245,3455,1223,386
Noncurrent Assets
Operating lease, right-of-use asset5748211,000275✕✕
Property, plant and equipment4,1944,6307,8148,2328,5272,695
Long-term investments and receivables9,0169,016    
Long-term investments9,0169,016    
Intangible assets, net (including goodwill)259259259509259 
Intangible assets, net (excluding goodwill)259259259509259 
Deposits noncurrent assets166188264   
Disposal group, including discontinued operation, noncurrent assets   20191229
Other undisclosed noncurrent assets    337279181
Total noncurrent assets:14,21014,9159,5399,3639,0772,905
TOTAL ASSETS:20,57319,63512,26214,70814,1996,291
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,07828,97334,82629,64920,26811,128
Taxes payable✕✕1,3371,4391,3741,4011,972
Accounts payable11,51412,13514,25213,6918,1564,189
Accrued liabilities19,56415,50019,13614,58410,7114,967
Debt8,8438,44313,02529,87412,7761,616
Derivative instruments and hedges, liabilities455455455455350 
Disposal group, including discontinued operation1,4561,4493,8142,7932,2981,973
Due to related parties✕ 2,4272,39715,7591,2001,329
Other undisclosed current liabilities7,4764,6154,6604,8887,5248,837
Total current liabilities:49,30846,36259,17883,41844,41624,882
Noncurrent Liabilities
Long-term debt and lease obligation 5742,024159 3,752
Long-term debt, excluding current maturities  1,196  3,752
Liabilities, other than long-term debt359 78  12,435
Accounts payable and accrued liabilities      
Disposal group, including discontinued operation, liabilities   78   
Operating lease, liability359574827159✕✕
Derivative instruments and hedges, liabilities      12,435
Other undisclosed noncurrent liabilities  (574)  32 
Total noncurrent liabilities:3595742,1021593216,187
Total liabilities:49,66746,93661,28083,57744,44841,069
Temporary equity, including noncontrolling interest      5,835
Equity
Equity, attributable to parent, including:(29,095)(27,302)(49,018)(76,520)(39,168)(40,613)
Common stock2,9080496513198
Additional paid in capital1,671,5721,342,086819,494509,437375,846128,352
Accumulated deficit(1,703,578)(1,369,408)(868,537)(586,942)(415,047)(169,180)
Other undisclosed equity, attributable to parent32021202018
Equity, attributable to noncontrolling interest      
Other undisclosed equity    7,6508,919 
Total equity:(29,095)(27,302)(49,018)(68,869)(30,248)(40,613)
TOTAL LIABILITIES AND EQUITY:20,57319,63512,26214,70814,1996,291

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues13,0003,2247,20015,98714,54938
Other income     67338
Cost of revenue(7,237)(5,936)(12,485)(14,845)(11,510)(949)
Cost of product and service sold(6,768)(5,292)(11,784)(14,845)(11,510)(949)
Gross profit:5,763(2,712)(5,284)1,1423,039(910)
Operating expenses(7,208)(9,808)(11,911)(32,318)(27,773)(20,696)
Other undisclosed operating income (loss)36  14,84511,5105,530
Operating income (loss):(1,410)(12,521)(17,195)(16,331)(13,225)(16,076)
Nonoperating income (expense)(1,552)7,428(1,757)(30,925)403(38,106)
Investment income, nonoperating   250 (4,277)
Other nonoperating income (expense)5005,3765,371(9,340)403(33,829)
Interest and debt expense335(2,200)(9,500)(9,500)(21,533)(8,649)
Loss from continuing operations before equity method investments, income taxes:(2,627)(7,293)(28,452)(56,756)(34,354)(62,831)
Other undisclosed income (loss) from continuing operations before income taxes(335)2,2009,5009,500  
Loss from continuing operations before income taxes:(2,962)(5,093)(18,952)(47,256)(34,354)(62,831)
Income tax expense(313)(180)(1,308) (766)(1,016)
Other undisclosed income from continuing operations   2,616   
Loss from continuing operations:(3,275)(5,272)(17,644)(47,256)(35,120)(63,847)
Income (loss) before gain (loss) on sale of properties:✕✕5,605(18,340)(48,034)(35,120)(68,022)
Income (loss) from discontinued operations(18)10,878(696)(778) (4,175)
Net income (loss):(3,293)5,605(18,340)(48,034)(35,120)(68,022)
Net income attributable to noncontrolling interest      
Other undisclosed net income attributable to parent     21,09812,824
Net income (loss) attributable to parent:(3,293)5,605(18,340)(48,034)(14,022)(55,198)
Preferred stock dividends and other adjustments (330,876)(506,477)(263,255)   
Other undisclosed net loss available to common stockholders, basic    (123,862)(231,844)(53,342)
Net loss available to common stockholders, diluted:(334,169)(500,872)(281,594)(171,895)(245,866)(108,540)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(3,293)5,605(18,340)(48,034)(35,120)(68,022)
Other comprehensive income  600    
Comprehensive income (loss):(3,293)6,205(18,340)(48,034)(35,120)(68,022)
Comprehensive income, net of tax, attributable to noncontrolling interest      
Comprehensive income (loss), net of tax, attributable to parent:(3,293)6,205(18,340)(48,034)(35,120)(68,022)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: